Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 12/8/2020
SIETES contiene 93083 citas

 
 
 1 a 20 de 686 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Trubiano JA, Adkinson NF, Phillips EJ. Penicillin allergy Is not necessarily forever. JAMA 2017;318:82-3. [Ref.ID 102053]
2. Cita con resumen
Anónimo. Five facts about cancer survival in England. BMJ 2016;353:i3314. [Ref.ID 100437]
3. Cita con resumen
Redberg RF. Fecal blood testing or colonoscopy. What is the best method for colorectal cancer screening?. JAMA Intern Med 2016;176:1071-3. [Ref.ID 100420]
4. Cita con resumen
Gray SL, Dublin S, Yu O, Walker R, Anderson M, Hubbard RA, Crane PK, Larson EB. Benzodiazepine use and risk of incident dementia or cognitive decline: prospective population based study. BMJ 2016;352:i90. [Ref.ID 100037]
5. Cita con resumen
McCarthy M. US panel recommends depression screening for all adults. BMJ 2016;352:i573. [Ref.ID 100035]
6. Cita con resumen
Svennberg E, Engdahl J, Al-Khalili F, Friberg L, Frykman V, Rosenqvist M. Mass screening for untreated atrial fibrillation The STROKESTOP study. Circulation 2015;131:2176-84. [Ref.ID 99252]
7. Cita con resumen
Sawaya GF, Kulasingam S, Denberg T, Qaseem A, for the Clinical Guidelines Committee of the American College of Physicians. Cervical cancer screening in average-risk women: best practice advice from the Clinical Guidelines Committee of the American College of Physicians. Ann Intern Med 2015;162:851-9. [Ref.ID 99017]
9. Cita con resumen
Anónimo. A stool DNA test (Cologuard) for colorectal cancer screening. Med Lett Drugs Ther 2014;56:100-1. [Ref.ID 98236]
10. Cita con resumen
LeBlanc E, Chou R, Zakher B, Daeges M, Pappas M. Screening for vitamin D deficiency: systematic evidence review of the U.S. Preventive Services Task Force recommendation. U.S. Preventive Services Task Force 2014:junio. [Ref.ID 97711]
11. Cita con resumen
Pollack A. F.D.A. panel recommends replacement for the Pap test . N Y Times (Print) 2014:12 de marzo. [Ref.ID 97518]
12. Cita con resumen
Anónimo. FDA approves first human papillomavirus test for primary cervical cancer screening . U.S. Food and Drug Administration 2014:24 de abril. [Ref.ID 97455]
13. Cita con resumen
Corley DA, Jensen ChD, Marks AR, Zhao WK, Lee JK, Doubeni ChA, Zauber AG, de Boer J, Fireman BH, Schottinger JE, Quinn VP, Ghai NR, Levin TR, Quesenberry ChP. Adenoma detection rate and risk of colorectal cancer and death. N Engl J Med 2014;370:1298-306. [Ref.ID 97371]
14. Cita con resumen
Arie S. Switzerland debates dismantling its breast cancer screening programme. BMJ 2014;348:g1625. [Ref.ID 97327]
15. Cita con resumen
Churchyard GJ, Fielding KL, Lewis JJ, Coetzee L, Corbett EL, Chir B, Godfrey-Faussett P, Hayes RJ, Chaisson RE, Grant AD, for the Thibela TB Study Team. A trial of mass isoniazid preventive therapy for tuberculosis control . N Engl J Med 2014;370:301-10. [Ref.ID 97030]
16. Cita con resumen
Sanfélix-Genovés J, Catalá-López F, Sanfélix-Gimeno G, Hurtado I, Baixauli C, Peiró S. Variabilidad en las recomendaciones para el abordaje clínico de la osteoporosis. Med Clin (Barc) 2014;142:15-22. [Ref.ID 97016]
18.
Kitchener HC, Denton K, Soldan K, Crosbie EJ. Developing role of HPV in cervical cancer prevention. BMJ 2013;347:26-31. [Ref.ID 96170]
19. Cita con resumen
20.Tiene citas relacionadas Cita con resumen
Independent UK Panel on Breast Cancer Screening. The benefits and harms of breast cancer screening — Authors' reply. Lancet 2013;381:803-4. [Ref.ID 95084]
Seleccionar todas
 
 1 a 20 de 686 siguiente >>